Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on P1 Int. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN106316957A offers high-purity Edaravone impurity intermediate synthesis with mild conditions and reduced costs for pharmaceutical supply chains.
Patent CN104693092A reveals a one-step synthesis for PTP1B inhibitors. Discover cost reduction and supply chain advantages for high-purity pharmaceutical intermediates.
Novel telescoping route for DPP1 inhibitor intermediate ensures high purity and scalable production for global pharmaceutical supply chains seeking cost reduction.